Abstract
Carotid intima-media thickness (IMT) and vascular inflammatory markers have been shown to be involved in atherosclerosis. This study was designed to investigate the effect of transdermal hormone replacement therapy (HRT) on carotid IMT and vascular inflammatory markers in postmenopausal women and to explore the interrelationship between the change in carotid IMT and the changes in vascular inflammatory markers. Thirty-five postmenopausal women (mean age 57.0±7.7 years) received transdermal HRT (continuous 17β-estradiol patch [36 μg/day] plus cyclic oral medroxyprogesterone acetate [2.5 mg/day, for 12 days/month]) for 12 months, and 32 controls (mean age 58.0±7.5 years) did not. Carotid IMT, assessed by ultrasound, and circulating vascular inflammatory markers, i.e., C-reactive protein (CRP), intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, E-selectin, monocyte chemoattractant protein (MCP)-1, and matrix metalloproteinase (MMP)-9 were measured before and after 12 months of treatment. In the HRT group, carotid IMT decreased significantly (p<0.01), from 0.71±0.13 mm to 0.65±0.12 mm, and the ICAM-1, VCAM-1, E-selectin, and MCP-1 levels decreased significantly (p<0.01 for all), but the CRP and MMP-9 levels remained unchanged. Carotid IMT and vascular inflammatory markers were unchanged in the control group. In the HRT group, the change in carotid IMT was significantly correlated with the change in serum E-selectin (r=0.38, p<0.05), but not with the changes in other vascular inflammatory markers. These results suggest that transdermal HRT reduced carotid artery wall thickness, and that the reduction may have been induced by an antiatherosclerotic effect combined with the direct effect of estrogen and decreased levels of estrogen-induced E-selectin.
Similar content being viewed by others
Article PDF
References
Salonen JT, Salonen R : Ultrasound B-mode imaging in observational studies of atherosclerotic progression. Circulation 1993; 87 ( Suppl II): II56–II65.
Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE : Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997; 96: 1432–1437.
O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr, for the Cardiovascular Health Study Collaborative Research Group : Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med 1999; 340: 14–22.
Kato J, Aihara A, Kikuya M, et al: Risk factors and predictors of coronary arterial lesions in Japanese hypertensive patients. Hypertens Res 2001; 24: 3–11.
Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH : Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998; 98: 731–733.
Hwang SJ, Ballantyne CM, Sharrett AR, et al: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation 1997; 96: 4219–4225.
Yla-Herttuala S, Lipton BA, Rosenfeld ME, et al: Expression of monocyte chemoattractant protein-1 in macrophage rich areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A 1991; 88: 5252–5256.
Stork S, Baumann K, von Schacky C, Angerer P : The effect of 17β-estradiol on MCP-1 serum levels in postmenopausal women. Cardiovasc Res 2002; 53: 642–649.
Jones CB, Sane DC, Herrington DM : Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome. Cardiovasc Res 2003; 59: 812–823.
Kai H, Ikeda H, Yasukawa H, et al: Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368–372.
Lynch JR, Blessing R, White WD, Grocott HP, Newman MF, Laskowitz DT : Novel diagnostic test for acute stroke. Stroke 2004; 35: 57–63.
Writing Group for the Women's Health Initiative Investigators : Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative Randomized Controlled Trial. JAMA 2002; 288: 321–333.
Women's Health Initiative Steering Committee : Effects of conjugated equine estrogen in postmenopausal women with hysterectomy. The Women's Health Initiative Randomized Controlled Trial. JAMA 2004; 291: 1701–1712.
Seljeflot I, Arnesen H, Hofstad AE, Os I : Reduced expression of endothelial cell markers after long-term transdermal hormone replacement therapy in women with coronary artery disease. Thromb Haemost 2000; 83: 944–948.
Sumino H, Ichikawa S, Ohyama Y, et al: Effect of transdermal hormone replacement therapy on the monocyte chemoattractant protein-1 concentrations and other vascular inflammatory markers and on endothelial function in postmenopausal women. Am J Cardiol 2005; 96: 155–160.
Tremollieres FA, Cigagna F, Alquier C, Cauneille C, Pouilles J, Ribot C : Effect of hormone replacement therapy on age-related increase in carotid artery intima-media thickness in postmenopausal women. Atherosclerosis 2000; 153: 81–88.
Kohara K, Tabara Y, Yamamoto Y, Igase M, Nakura J, Miki T : Genotype-specific association between circulating soluble cellular adhesion molecules and carotid intima-media thickness in community residents: J-SHIPP study. Shimanami Health Promoting Program. Hypertens Res 2002; 25: 31–39.
Tabara Y, Kohara K, Yamamoto Y, et al: Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 2003; 26: 677–683.
Kohara K, Tabara Y, Tachibana R, Nakura J, Miki T : Microalbuminuria and arterial stiffness in a general population: the Shimanami Health Promoting Program (J-SHIPP) study. Hypertens Res 2004; 27: 471–477.
Beldekas JC, Gerstenfeld L, Sonenshein GE, Franzblau C : Cell density and estradiol modulation of procollagen type III in cultured calf smooth muscle cells. J Biol Chem 1982; 257: 12252–12256.
Fischer GM, Swain ML : Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis 1985; 54: 177–185.
Dubey RK, Gillespie DG, Jackson EK, Keller PJ : 17Beta-estradiol, its metabolites, and progesterone inhibit cardiac fibroblast growth. Hypertension 1998; 31: 522–528.
Vongpatanasin W, Tuncel M, Wang Z, Arbique D, Mehrad B, Jialal I : Differential effects of oral versus transdermal estrogen replacement therapy on C-reactive protein in postmenopausal women. J Am Coll Cardiol 2003; 41: 1358–1363.
Wakatsuki A, Ikenoue N, Shinohara K, Watanabe K, Fukaya T : Different effects of oral and transdermal estrogen replacement therapy on matrix metalloproteinase and their inhibitor in postmenopausal women. Arterioscler Thromb Vasc Biol 2003; 23: 1948–1949.
Zwaka TP, Hombach V, Torzewski J : C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001; 103: 1194–1197.
O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE : Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 1996; 93: 672–682.
Koh KK, Jin DK, Yang SH, et al: Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women. Circulation 2001; 103: 1961–1966.
Seli E, Pehlivan T, Selam B, Garcia-Velasco JA, Arici A : Estradiol down-regulates MCP-1 expression in human coronary artery endothelial cells. Fertil Steril 2002; 77: 542–547.
Hayashi T, Jayachandran M, Sumi D, et al: Physiological concentration of 17 beta-estradiol retards the progression of severe atherosclerosis induced by a high-cholesterol-diet and balloon catheter injury. Role of NO. Arterioscler Thromb Vasc Biol 2000; 20: 1613–1621.
Zeiher AM, Fisslthaler B, Schray-Utz B, Busse R : Nitric oxide modulates the expression of monocyte chemotactic protein-1 in cultured endothelial cells. Circ Res 1995; 76: 980–986.
Zanger D, Yang BK, Ardans J, et al: Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. J Am Coll Cardiol 2000; 36: 1797–1802.
Vehkavaara S, Silveira A, Hakala-Ala-Pietila T, et al: Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women. Thromb Haemost 2001; 85: 619–625.
Wakatsuki A, Okatani Y, Ikenoue N, Fukaya T : Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low-density lipoprotein particles in postmenopausal women. Circulation 2002; 106: 1771–1776.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sumino, H., Ichikawa, S., Kasama, S. et al. Effect of Transdermal Hormone Replacement Therapy on Carotid Artery Wall Thickness and Levels of Vascular Inflammatory Markers in Postmenopausal Women. Hypertens Res 28, 579–584 (2005). https://doi.org/10.1291/hypres.28.579
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1291/hypres.28.579
Keywords
This article is cited by
-
Associations of estradiol levels and genetic polymorphisms of inflammatory genes with the risk of ischemic stroke
Journal of Biomedical Science (2017)
-
Arterial Remodeling in B-Type Natriuretic Peptide Knock-Out Females
Scientific Reports (2016)
-
Correlation between small dense low-density lipoprotein cholesterol and carotid artery intima-media thickness in a healthy Chinese population
Lipids in Health and Disease (2015)
-
Female sex hormones mediate the allergic lung reaction by regulating the release of inflammatory mediators and the expression of lung E-selectin in rats
Respiratory Research (2010)